Brief: PCI Biotech Updates On Evaluation Of Operations
23/10/2025 09:36
Oct 23 (Reuters) - PCI Biotech Holding ASA PCIB.OL: UPDATES ON EVALUATION OF OPERATIONS LIQUIDITY POSITION CRITICAL, FINANCING UNCERTAIN COMPANY'S FUTURE RELIES ON TECHNOLOGY EVALUATION INTEREST MANAGEMENT TEAM HAS BEEN RESTRUCTURED AND NOW CONSISTS SOLELY OF CEO POSITION IN PARENT COMPANY, PCI BIOTECH HOLDING ASA THESE MATERIAL UNCERTAINTIES CAST SIGNIFICANT DOUBT ON PCI BIOTECH GROUP'S ABILITY TO CONTINUE AS A GOING CONCERN Source text: ID:nGNE4Pv7qC Further company coverage: PCIB.OL (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process